Health 8 sources · over 3 days 14 articles

Maharashtra FDA Uncovers Extreme Markups on Medical Devices, Seeks Price Caps

After discovering IV sets bought for Rs 11 billed at Rs 325, Maharashtra's FDA is urging national intervention to regulate medical device prices and protect patients from excessive costs.

Read the full story → · Latest coverage 18 Sept 2026, 11:19 am UTC

Key moments · 8

FDA exposes massive markup on IV sets in hospitals

Indian Express ↗

FDA commissioner highlights burden on patients via social media

India News ↗

Survey reveals 2,800 percent markup on medical consumables

India Today ↗

FDA requests government price caps and transparency

Mint ↗

FDA submits recommendations to NPPA for pricing guidelines

The Hindu ↗

Public debate grows over hospital billing practices

Times of India India ↗

FDA urges central government to investigate and regulate pricing

The Hindu ↗

Media spotlights price manipulation in India's private hospitals

Indian Express ↗

Coverage by day

newest first

2 articles

  1. In India’s private hospitals, MRP means ‘Manipulated Raised Price’
    Indian Express
  2. FDA chief Tukaram flags huge price gaps in medical devices, seeks Centre’s intervention
    The Hindu

3 articles

  1. Maharashtra FDA Commissioner made recommendation to NPPA on pricing gap of hospital consumables
    The Hindu
  2. Hospitals could be charging you 2,841% higher on commonly used consumables
    Times of India India
  3. Hospitals could be charging 2,841% higher on commonly used consumables
    Times of India

9 articles

  1. Exclusive: After Survey Flags 2,800% Pharma Profit, Tukaram Mundhe Calls For Transparency
    NDTV Top Stories
  2. 2,800% markup? Mundhe says consumers can't be taken for a ride on medical pricing
    India Today
  3. IV set bought for Rs 11, sold with Rs 325 MRP: Maharashtra FDA seeks price caps
    Indian Express
  4. Medicine worth Rs 11 billed at Rs 325 in private hospitals, Tukaram Mundhe exposes huge pricing gap, orders crackdown
    India News
  5. Trade margins on medical devices in sharp focus, again, following Maharashtra FDA survey
    Business Line - Home